6. Executive KMP Outcomes in FY26 6.1 FY26 STI Outcomes For FY26, the Board considered CSL's overall financial outcomes, including the impairments, and decided to exercise its overarching discretion to reduce Executive KMP STI outcomes below what would have been paid on the basis of the targets set at the start of the year. The Board's intention in making these adjustments was to ensure the STI outcomes were appropriately aligned with the overall performance of the company and the experience of CSL’s shareholders. The performance outcomes achieved resulted in Dr McKenzie, Ms Linton and Mr Schmeltz receiving no STI payments in relation to FY26. Mr Lim, who was promoted to Chief Financial Officer during the year, received an FY26 STI payment of 25% of target. In light of the Board exercising its overarching discretion, the Leading and Managing Modifier was not required, and the Board made no adjustments under the Malus and Clawback Policy. Table 4: CSL Group KPI outcomes in FY26 Measure Performance Outcomes Commentary NPATA – The NPATA outcome was below threshold, resulting in a zero contribution to STI. CFO – CFO remained resilient despite the Company's other performance challenges, demonstrating ongoing strength in the underlying business. CFO was broadly flat year on year. – The outcome would have delivered between target and threshold outcome for STI purposes, (prior to the exercise of the Board's overarching discretion). The resilient cash position has enabled the company to maintain dividend per share, expand the share buy back programme and maintain leverage at 1.8. Sustainability (milestones) – Of the six sustainability priorities, four achieved between threshold and target. One priority area significantly exceeded target and one failed to achieve threshold. – Key achievements and further information on CSL’s sustainability strategy can be found in the Healthier World > Healthier Environment section of the Annual Report. In addition to the above Group metrics, each Executive had a scorecard of individual KPIs set at the start of FY26. These were assessed rigorously in the usual manner, but were ultimately of little consequence, with the Board deciding to apply overarching discretion to reduce overall STI outcomes to 25% of target for Mr Lim, and to zero for the other Executive KMP. CSL Limited Annual Report 2025/26 1373 CSL Limited Annual Report 2025/26
RkJQdWJsaXNoZXIy MjE2NDg3